Brazil
8 Vaccines Approved for Use in Brazil
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
6 trials in 1 country
Approval Source: bio.fiocruz.br
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 93 countries
39 trials in 18 countries
Approval Source: gov.br
Inactivated
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
14 in Clinical Trials in Brazil
Protein Subunit
Clover
SCB-2019
15 trials in 13 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
DNA
Inovio
INO-4800
10 trials in 9 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
AZD2816
2 trials in 2 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)
8 trials in 4 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Non Replicating Viral Vector
Mahidol University
NDV-HXP-S
7 trials in 3 countries
Protein Subunit
University of Saskatchewan
COVAC-1
RNA
SENAI CIMATEC
HDT-301
2 trials in 1 country
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
1 Vaccines with Trials in Brazil are No Longer Progressing
Non Replicating Viral Vector
Oxford/AstraZeneca
AZD2816
2 trials in 2 countries